CYTK position history
The shares of Cytokinetics (CYTK) that Palo Alto Investors LP reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 123,686 shares, $4.4M, 0.27% of portfolio
- 2021 Q4: 123,686 shares, $5.6M, 0.36% of portfolio
- 2022 Q1: 111,717 shares, $4.1M, 0.32% of portfolio, Reduce −9.7%
- 2022 Q2: 111,717 shares, $4.4M, 0.38% of portfolio
- 2022 Q3: 111,717 shares, $5.4M, 0.43% of portfolio
- 2022 Q4: 111,717 shares, $5.1M, 0.44% of portfolio
- 2023 Q1: 111,717 shares, $3.9M, 0.33% of portfolio
- 2023 Q2: 111,717 shares, $3.6M, 0.29% of portfolio
- 2023 Q3: 111,717 shares, $3.3M, 0.31% of portfolio
- 2023 Q4: 223,434 shares, $19M, 1.7% of portfolio, Add +100.0%
- 2024 Q1: 111,717 shares, $7.8M, 0.88% of portfolio, Reduce −50.0%
- 2024 Q2: 111,717 shares, $6.1M, 0.70% of portfolio
- 2024 Q3: not held, Exit
- 2024 Q4: not held
- 2025 Q1: not held
- 2025 Q2: not held
- 2025 Q3: not held
- 2025 Q4: not held
- 2026 Q1: 32,195 shares, $2.1M, 0.32% of portfolio, New
- 2026 Q2: 32,195 shares, $2.7M, 0.38% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|